Xue J H, Takahashi H, Yamaguchi M
Laboratory of Endocrinology and Molecular Metabolism, Graduate School of Nutritional Sciences, University of Shizuoka, Shizuoka, Japan.
J Cell Biochem. 2000 Oct 20;80(2):285-92. doi: 10.1002/1097-4644(20010201)80:2<285::aid-jcb180>3.0.co;2-5.
The effect of regucalcin, which is a regulatory protein of Ca(2+) signaling, on Ca(2+)-ATPase activity in isolated rat renal cortex mitochondria was investigated. The presence of regucalcin (50, 100, and 250 nM) in the enzyme reaction mixture led to a significant increase in Ca(2+)-ATPase activity. Regucalcin significantly stimulated ATP-dependent (45)Ca(2+) uptake by the mitochondria. Ruthenium red (10(-6) M) or lanthunum chloride (10(-6) M), an inhibitor of mitochondrial Ca(2+) uptake, markedly inhibited regucalcin (100 nM)-increased mitochondrial Ca(2+)-ATPase activity and (45)Ca(2+) uptake. The effect of regucalcin (100 nM) in elevating Ca(2+)-ATPase activity was completely prevented by the presence of digitonin (10(-2)%), a solubilizing reagent of membranous lipids, vanadate, an inhibitor of phosphorylation of ATPase, or dithiothreitol (50 mM), a protecting reagent of the sulfhydryl (SH) group of the enzyme. The activating effect of regucalcin (100 nM) on Ca(2+)-ATPase activity was not further enhanced by calmodulin (0.30 microM) or dibutyryl cyclic AMP (10(-4) M), which could increase Ca(2+)-ATPase activity. Trifluoperazine (TFP; 50 microM), an antagonist of calmodulin, significantly decreased Ca(2+)-ATPase activity. The activating effect of regucalcin on the enzyme was also seen in the presence of TFP, indicating that regucalcin's effect is not involved in mitochondrial calmodulin. The present study demonstrates that regucalcin can stimulate Ca(2+)-pump activity in rat renal cortex mitochondria, and that the protein may act on an active site (SH group) related to phosphorylation of mitochondrial Ca(2+)-ATPase.
研究了作为Ca(2+)信号调节蛋白的调钙素对离体大鼠肾皮质线粒体中Ca(2+)-ATP酶活性的影响。酶反应混合物中存在调钙素(50、100和250 nM)会导致Ca(2+)-ATP酶活性显著增加。调钙素显著刺激线粒体对ATP依赖的(45)Ca(2+)摄取。线粒体Ca(2+)摄取抑制剂钌红(10(-6) M)或氯化镧(10(-6) M)显著抑制调钙素(100 nM)增加的线粒体Ca(2+)-ATP酶活性和(45)Ca(2+)摄取。膜脂增溶剂洋地黄皂苷(10(-2)%)、ATP酶磷酸化抑制剂钒酸盐或酶巯基(SH)基团保护剂二硫苏糖醇(50 mM)的存在完全阻止了调钙素(100 nM)提高Ca(2+)-ATP酶活性的作用。钙调蛋白(0.